{
  "docId": "019de06f-57cf-712e-a58f-75e608a89acf",
  "docSlug": "72cbc476cbb3df5012eb344c4961ce5a",
  "documentTitle": "Bausch Health Companies | Mergers and Acquisitions Presentation Deck | 40 slides",
  "authorId": "bausch-health-companies",
  "authorName": "Valeant",
  "documentKindSlug": "consulting-deck",
  "documentKindLabel": "Consulting deck",
  "sourceTypeSlug": "investment_bank",
  "sourceTypeLabel": "Investment bank",
  "presentationDate": "2014-09-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.5571777,
  "pageNumber": 34,
  "pageCount": 40,
  "prevPage": 33,
  "nextPage": 35,
  "slideType": "situation_overview",
  "function": "establish_context",
  "density": "balanced",
  "nDataPoints": 2,
  "notes": "The slide outlines the procedural steps for a hostile takeover or activist campaign by Valeant against Allergan.",
  "elementsJson": null,
  "metadataConfidence": 0.95,
  "imagePath": null,
  "slideHref": "/slides/019de06f-57cf-712e-a58f-75e608a89acf/34",
  "deckHref": "/decks/019de06f-57cf-712e-a58f-75e608a89acf",
  "deckJsonHref": "/decks/019de06f-57cf-712e-a58f-75e608a89acf.json",
  "deckAnchorHref": "/decks/019de06f-57cf-712e-a58f-75e608a89acf#slide-34",
  "components": [
    {
      "bbox": {
        "h": 0.6,
        "w": 0.4,
        "x": 0.3,
        "y": 0.25
      },
      "kind": "image",
      "text": null,
      "attrs": null,
      "subkind": "illustration",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "eb3e12db-7238-4489-b4be-e544b37d271e",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.6,
        "w": 0.9,
        "x": 0.06,
        "y": 0.2
      },
      "kind": "list",
      "text": "Presented requests for Special Meeting to Allergan from stockholders of over 35% of Allergan's outstanding share\nSpecial meeting called for Dec. 18th\nAt Special Meeting, Allergan stockholders will vote on resolutions to:\n- Remove six members of Allergan's current board of directors\n- Request that Allergan board of directors appoint a slate of 6 new independent directors\n- Amend Allergan's bylaws to provide for, among other things, simplified mechanics to call a special meeting\n- Request that the Allergan board of directors promptly engage in good faith discussions with Valeant\nWe are confident that Allergan shareholders will agree that there is tremendous strategic and financial logic in the Allergan-Valeant combination.",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "fffe7e67-1a2c-4e93-bc4c-5e6a8a5b6735",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.06,
        "w": 0.3,
        "x": 0.06,
        "y": 0.06
      },
      "kind": "title",
      "text": "Allergan Update",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "97b66e8f-5188-4e2f-b7bc-08eadc596c90",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [],
  "arcBeats": [
    {
      "to": 39,
      "from": 33,
      "beatId": "cd21e60c-5f8c-4e21-b4ee-841538c314d4",
      "arcName": "The Consultant's Gambit",
      "arcSlug": "consultants-gambit",
      "beatName": "Impact & Next Steps",
      "beatSlug": "consultants-gambit-impact-next-steps",
      "evidence": "Integration plans, initiative lists, and future collaboration objectives",
      "position": 3,
      "confidence": 0.8,
      "parentBeatName": "Resolution",
      "parentBeatSlug": "resolution"
    }
  ],
  "loops": [
    {
      "to": 36,
      "from": 33,
      "name": "Quick Win Big Bet",
      "slug": "47-quick-win-big-bet",
      "bestFor": "Transformation planning, 100-day plans, resource allocation",
      "matchId": "23839434-41d6-4f96-add5-e31951b94151",
      "evidence": "Integration plans and guiding principles",
      "position": 1,
      "objective": "Identify quick wins and big bets for Allergan integration",
      "structure": "The Full List -> Quick Wins (Low effort, High impact) -> Big Bets (High effort, High impact) -> Sequenced Roadmap",
      "confidence": 0.6,
      "description": "Separate initiatives into immediate wins and longer-term strategic bets"
    }
  ],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}